Please use this identifier to cite or link to this item:
https://doi.org/10.1039/d1ra04528h
Title: | H2O2self-providing synergistic chemodynamic/photothermal therapy using graphene oxide supported zero valence iron nanoparticles | Authors: | Xu, Miao Li, Qin Xiang, Yi Yuan, Shanshan Wu, Yihan Zhang, Jing Liu, Jinliang Zhu, Xiaohui Zhang, Yong |
Issue Date: | 1-Jan-2021 | Publisher: | Royal Society of Chemistry | Citation: | Xu, Miao, Li, Qin, Xiang, Yi, Yuan, Shanshan, Wu, Yihan, Zhang, Jing, Liu, Jinliang, Zhu, Xiaohui, Zhang, Yong (2021-01-01). H2O2self-providing synergistic chemodynamic/photothermal therapy using graphene oxide supported zero valence iron nanoparticles. RSC Advances 11 (46) : 28973-28987. ScholarBank@NUS Repository. https://doi.org/10.1039/d1ra04528h | Rights: | Attribution 4.0 International | Abstract: | Chemodynamic therapy (CDT) represents an emerging modality that treats cancer and other malignant diseases by using Fenton or Fenton-like catalysts to decompose hydrogen peroxide (H2O2) into toxic hydroxyl radicals (·OH). Despite its great promise, chemodynamic therapy is still limited by low endogenous H2O2levels and lack of highly efficient nanocatalysts. In this study, we have developed multi-functional therapeutic nanocomposites GO-ZVI-GOx (GO = graphene oxide, ZVI = zero valence iron nanoparticles and GOx = glucose oxidase), where the GOx can catalyze the intracellular glucose and self-produce H2O2for enhanced CDT therapy, and the GO is used as a template to avoid the aggregation of ZVI nanoparticles and also as an excellent photo-thermal converter for photothermal therapy under near-infrared (NIR) light. Our results show that this H2O2self-generating nanoplatform can produce substantial amounts of reactive radicals under 808 nm NIR light due to the combinational effect of dual chemodynamic and photothermal therapy, which eventually leads to a significant decrease in cancer cell viability. It is believed that the methodology developed in this study enables conventional chemodynamic therapy to be efficiently improved, and holds great potential for overcoming challenges in many other H2O2-dependent cancer therapies. © The Royal Society of Chemistry 2021. | Source Title: | RSC Advances | URI: | https://scholarbank.nus.edu.sg/handle/10635/232052 | ISSN: | 2046-2069 | DOI: | 10.1039/d1ra04528h | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1039_d1ra04528h.pdf | 2.34 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License